QCG
SGMO

Quadrant Capital Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Quadrant Capital Group’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-13,249
Closed -$23.3K – 2764
2023
Q1 		$23.3K Buy
13,249
+515
+4% +$1.47K ﹤0.01% 1623
2022
Q4 		$40K Buy
12,734
+11,392
+849% +$44.2K ﹤0.01% 1301
2022
Q3 		$7K Sell
1,342
-2,550
-66% -$13.1K ﹤0.01% 2033
2022
Q2 		$16K Buy
3,892
+3,729
+2,288% +$16.1K ﹤0.01% 1423
2022
Q1 		$1K Buy
+163
New +$969 ﹤0.01% 2384
2020
Q2 		– Sell
-89
Closed – – 2377
2020
Q1 		$0 Buy
89
+30
+51% +$223 ﹤0.01% 2247
2019
Q4 		$0 Hold
59
– – ﹤0.01% 2481
2019
Q3 		$0 Hold
59
– – ﹤0.01% 2377
2019
Q2 		$0 Hold
59
– – ﹤0.01% 2390
2019
Q1 		$0 Hold
59
– – ﹤0.01% 2326
2018
Q4 		$0 Hold
59
– – ﹤0.01% 2281
2018
Q3 		$1K Hold
59
– – ﹤0.01% 2037
2018
Q2 		$0 Sell
59
-455
-89% -$7.56K ﹤0.01% 2195
2018
Q1 		$9K Hold
514
– – ﹤0.01% 1317
2017
Q4 		$8K Hold
514
– – ﹤0.01% 1292
2017
Q3 		$7K Hold
514
– – ﹤0.01% 1345
2017
Q2 		$4K Hold
514
– – ﹤0.01% 1431
2017
Q1 		$2K Buy
+514
New +$2.06K ﹤0.01% 1652

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quadrant Capital Group's SGMO Position: Q2 2023 in Review

Quadrant Capital Group sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2023, closing a stake of 13,249 shares — an estimated $23.3K sold.

Quadrant Capital Group first reported a position in SGMO in Q1 2017 and held it in 18 quarters. The position peaked at $40K in Q4 2022. 152 funds tracked by Wall St. Rank hold SGMO as of Q2 2023.

  • Quadrant Capital Group reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2023 after selling out during the quarter.
  • Quadrant Capital Group sold 13,249 SANGAMO THERAPEUTICS INC shares in Q2 2023, an estimated $23.3K.
  • Quadrant Capital Group first reported a position in SANGAMO THERAPEUTICS INC in Q1 2017 and held it in 18 quarters.
  • Quadrant Capital Group's SANGAMO THERAPEUTICS INC position peaked at $40K in Q4 2022.
  • 152 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2023.

Based on Quadrant Capital Group's 13F filing for Q2 2023, filed 10 Aug 2023.